Cas:41902-42-5 3-tert-butyl-2,2,4,4-tetramethylpentan-3-ol manufacturer & supplier

We serve Chemical Name:3-tert-butyl-2,2,4,4-tetramethylpentan-3-ol CAS:41902-42-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-tert-butyl-2,2,4,4-tetramethylpentan-3-ol

Chemical Name:3-tert-butyl-2,2,4,4-tetramethylpentan-3-ol
CAS.NO:41902-42-5
Synonyms:tri-tert-butylcarbinol;2,2,4,4-tetramethyl-3-tert-butyl-pentan-3-ol;2,2,4,4-Tetramethyl-3-t-butyl-pentane-3-ol;tri-tert-butyl-methanol;tris-tert-butanol;3-tert-Butyl-2,2,4,4-tetramethyl-3-pentanol
Molecular Formula:C13H28O
Molecular Weight:200.36100
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:204.4ºC at 760 mmHg
Density:0.831g/cm3
Index of Refraction:1.441
PSA:20.23000
Exact Mass:200.21400
LogP:3.85580

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like tri-tert-butylcarbinol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-tert-Butyl-2,2,4,4-tetramethyl-3-pentanol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,2,4,4-tetramethyl-3-tert-butyl-pentan-3-ol Use and application,tri-tert-butylcarbinol technical grade,usp/ep/jp grade.


Related News: Additionally, Charles River provides paid time-off for its employees to volunteer for charitable and community organisations. ethyl 3-[(S)-3-(tert-butoxycarbonyl)-2,2-dimethyloxazolidin-4-yl]-2-(trifluoromethyl)propanoate manufacturers As Natural Capsules did not have access to this manufacturing technology, its R&D centre, which is DSIR approved, had started working on the same since 2018, and has now successfully developed the process including fermentation and chemical synthesis steps, Sunil Mundra, managing director, Natural Capsules told Pharmabiz. tetra(p-methoxyphenyl)disilane suppliers The suit says that while BRAF kinase inhibitors existed prior to Plexxikon’s discoveries, they were not selective, and Plexxikon’s have a core molecular structure that allows them to bind selectively to kinase created by the BRAF mutation. That allows for higher doses to be administered. 4-[3-(cyclohexylamidyl)benzoyl]-1-methylpiperidine vendor & factory.